ASPEN position paper clinical role for alternative intravenous fat emulsions
Jump to navigation
Jump to search
Target Article[edit | edit source]
ASPEN position paper clinical role for alternative intravenous fat emulsions; VW Vanek, DL Seidner, P Allenae; 2012; doi_citing_unknown
Retraction[edit | edit source]
Retraction: Sudbø J et al. DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. The Influence of Resection and Aneuploidy on Mortality in Oral Leukoplakia. N Engl J Med 2004;350:1405-13; Sudbø J et al. ; 2006-11-2
Citation piece[edit | edit source]
Note: Open to append information.